Edilytics is hiring a Director of Business Development to assist in its mission to advance genome editing analysis. Our main product is CRISPResso, a genome editing quantification suite of software tools that measures genome editing outcomes from next-generation sequencing. CRISPResso is the gold standard in both academia and industry. This is your chance to influence thousands of scientists by driving the advancement of the genome editing community and playing a pivotal role in the creation of the next generation of CRISPR-based therapeutics.
This position will identify new commercial partners using digital outreach methods, as well as networking in-person. They will also help support our clients with troubleshooting and data analysis, and ensure customer satisfaction.
Success in this role looks like:
This role will be compensated with a competitive base salary, and commissions on the first and second year sales.
Edilytics is a hybrid company (mainly remote) with a team based in Utah. There are 3 full time software developers that work on CRISPResso and an executive team. We are a small team committed to making tools that are accurate and easy to use. We value our employees by offering flexible time off, generous 401k matching, and health insurance.
CRISPResso is open-source software designed by researchers at Harvard that has over 1,470 citations between the two papers. CRISPResso is available free for academic use, and requires a license for commercial use. Commercial CRISPResso users range from startup biotechs to large multinational pharmaceuticals. You can be an integral part of the next phase of Edilytics’s growth.
Interested? Please email Cole at contact@edilytics.com with a cover letter and CV.